Literature DB >> 8647639

International renal-cell-cancer study. VI. the role of medical and family history.

B Schlehofer1, W Pommer, A Mellemgaard, J H Stewart, M McCredie, S Niwa, P Lindblad, J S Mandel, J K McLaughlin, J Wahrendorf.   

Abstract

A number of medical conditions have been linked with renal-cell cancer, although the evidence is not consistent in every case. In a large international case-control study of renal-cell cancer, we examined, among other hypotheses, associations with a personal history of certain medical conditions and a family history of cancer of the kidney or thyroid. Relative risks (RR), adjusted for the effects of age, gender, body-mass index, tobacco smoking and study centre, were significantly increased by a history of kidney stones or thyroid or kidney disease. The RR were not altered by additional adjustment for hypertension, or when diagnoses were restricted to those made at least 5 or 10 years before 1987 (the usual "cut-off" date). The link with kidney injury is particularly likely to be affected by recall bias. Increased RR of borderline significance were found for kidney infection (RR, 1.2) and diabetes (RR, 1.4). Having one first-degree relative with kidney cancer was associated with a significantly increased risk of renal-cell cancer (RR, 1.6; 95% Cl, 1.1-2.4). Seven cases reported 2 first-degree relatives with kidney cancer. No controls had first-degree relatives with kidney cancer. None of our participants reported having von Hippel-Lindau disease. The data suggests that a few conditions of the kidney are strongly associated with renal-cell cancer and that heredity plays a role in a small proportion of cases.

Entities:  

Mesh:

Year:  1996        PMID: 8647639     DOI: 10.1002/(SICI)1097-0215(19960611)66:6<723::AID-IJC2>3.0.CO;2-1

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

1.  [Renal cell carcinoma].

Authors:  A Haferkamp; D Rohde; S C Müller; H Rübben; M Hohenfellner
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

2.  Family history and risk of renal cell carcinoma: results from a case-control study and systematic meta-analysis.

Authors:  Jessica Clague; Jie Lin; Adrian Cassidy; Surena Matin; Nizar M Tannir; Pheroze Tamboli; Christopher G Wood; Xifeng Wu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-24       Impact factor: 4.254

3.  Transient ischaemic attack secondary to paraneoplastic erythrocytosis.

Authors:  Aldo René Hurtarte Sandoval; Bryan Josué Flores Robles; Robert Francis Andrus; David Alejandro Yaxcal Chon
Journal:  BMJ Case Rep       Date:  2014-10-21

4.  The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma.

Authors:  Summer S Han; Meredith Yeager; Lee E Moore; Ming-Hui Wei; Ruth Pfeiffer; Ousmane Toure; Mark P Purdue; Mattias Johansson; Ghislaine Scelo; Charles C Chung; Valerie Gaborieau; David Zaridze; Kendra Schwartz; Neonilia Szeszenia-Dabrowska; Faith Davis; Vladimir Bencko; Joanne S Colt; Vladimir Janout; Vsevolod Matveev; Lenka Foretova; Dana Mates; M Navratilova; Paolo Boffetta; Christine D Berg; Robert L Grubb; Victoria L Stevens; Michael J Thun; W Ryan Diver; Susan M Gapstur; Demetrius Albanes; Stephanie J Weinstein; Jarmo Virtamo; Laurie Burdett; Antonin Brisuda; James D McKay; Joseph F Fraumeni; Nilanjan Chatterjee; Philip S Rosenberg; Nathaniel Rothman; Paul Brennan; Wong-Ho Chow; Margaret A Tucker; Stephen J Chanock; Jorge R Toro
Journal:  Hum Mol Genet       Date:  2011-11-23       Impact factor: 6.150

5.  A population-based study on the association between urinary calculi and kidney cancer.

Authors:  Shiu-Dong Chung; Shih-Ping Liu; Herng-Ching Lin
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

Review 6.  Precision medicine from the renal cancer genome.

Authors:  Yasser Riazalhosseini; Mark Lathrop
Journal:  Nat Rev Nephrol       Date:  2016-10-03       Impact factor: 28.314

7.  Family history of cancer and renal cell cancer risk in Caucasians and African Americans.

Authors:  S Karami; K Schwartz; M P Purdue; F G Davis; J J Ruterbusch; S S Munuo; S Wacholder; B I Graubard; J S Colt; W-H Chow
Journal:  Br J Cancer       Date:  2010-05-04       Impact factor: 7.640

8.  Energy balance, polymorphisms in the mTOR pathway, and renal cell carcinoma risk.

Authors:  Xiang Shu; Jie Lin; Christopher G Wood; Nizar M Tannir; Xifeng Wu
Journal:  J Natl Cancer Inst       Date:  2013-02-02       Impact factor: 13.506

9.  Fish, vitamin D, and flavonoids in relation to renal cell cancer among smokers.

Authors:  Robin Taylor Wilson; Jiangyue Wang; Vernon Chinchilli; John P Richie; Jarmo Virtamo; Lee E Moore; Demetrius Albanes
Journal:  Am J Epidemiol       Date:  2009-08-03       Impact factor: 4.897

10.  Variants in blood pressure genes and the risk of renal cell carcinoma.

Authors:  Gabriella Andreotti; Paolo Boffetta; Philip S Rosenberg; Sonja I Berndt; Sara Karami; Idan Menashe; Meredith Yeager; Stephen J Chanock; David Zaridze; Vsevolod Matteev; Vladimir Janout; Hellena Kollarova; Vladimir Bencko; Marie Navratilova; Neonilia Szeszenia-Dabrowska; Dana Mates; Nathaniel Rothman; Paul Brennan; Wong-Ho Chow; Lee E Moore
Journal:  Carcinogenesis       Date:  2010-01-04       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.